LA MIRADA, CA--(Marketwire - September 29, 2011) - BioLargo, Inc. (OTCBB: BLGO), creator of patented iodine technologies, today announced that the United States Patent and Trademark office had granted BioLargo two additional patents. The new patents advance intellectual property protection of BioLargo's core iodine technology. The first patent relates to the use of its iodine technology to eliminate germs in a confined area such as liquid circulation systems, dishwashers, refrigerators, freezers, vehicle cabs, and vehicle seating areas and includes gaseous iodine. The second patent issued advances protection of its core technology to include stabilization of the reactive components.
"These patent advancements are another milestone in our journey to continue building our robust intellectual property estate," stated BioLargo's chief technology officer Ken Code.
"We are thankful to add patent protection to our growing portfolio of intellectual property which includes our know-how and trade secrets. We have been fortunate to add key executives to our team over the past year with special expertise in their respective industries, like Vikram Rao, PhD, former CTO of Halliburton and Executive Director of the Research Triangle Energy Consortium; Mr. Harry DeLonge, former senior technical executive at Pepsi and top industry award winner from AWWA and International Society of Food and Beverage Technologists; Tim Johnson, who built and sold a successful medical device company to Smith and Nephew; and Richard Bickerstaff, PhD, chemist with over 20+ years of oil and gas industry experience. As we advance our proof of claims and intellectual property we also are more able to target specific product designs to meet and help solve some of the most pressing and important issues facing each of these industries. BioLargo's combination of technology and team is potent and rare," stated BioLargo's president Dennis Calvert. "We are in a great position to advance our business plans in these areas."
About BioLargo, Inc.
BioLargo's business strategy is to harness and deliver Nature's Best Solution™ -- free-iodine -- in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo's proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo's technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company's website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor's Choice Awards, including a "Product of the Year" award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo's wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in the BioLargo's Annual Report on Form 10-K for the year ended December 31, 2010.